Literature DB >> 25220500

Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells.

Nicole L Moore1, Dean P Edwards2, Nancy L Weigel3.   

Abstract

A role for the cell cycle protein cyclin A2 in regulating progesterone receptor (PR) activity is emerging. This study investigates the role of cyclin A2 in regulating endogenous PR activity in T47D breast cancer cells by depleting cyclin A2 expression and measuring PR target genes using q-RT-PCR. Targets examined included genes induced by the PR-B isoform more strongly than PR-A (SGK1, FKBP5), a gene induced predominantly by PR-A (HEF1), genes induced via PR tethering to other transcription factors (p21, p27), a gene induced in part via extra-nuclear PR signaling mechanisms (cyclin D1) and PR-repressed genes (DST, IL1R1). Progestin induction of target genes was reduced following cyclin A2 depletion. However, cyclin A2 depletion did not diminish progestin target gene repression. Furthermore, inhibition of the associated Cdk2 kinase activity of cyclin A2 also reduced progestin induction of target genes, while Cdk2 enhanced the interaction between PR and cyclin A2. These results demonstrate that cyclin A2 and its associated kinase activity are important for progestin-induced activation of endogenous PR target genes in breast cancer cells.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclin A2; Cyclin dependent kinase 2; Progesterone receptor

Mesh:

Substances:

Year:  2014        PMID: 25220500      PMCID: PMC4201666          DOI: 10.1016/j.jsbmb.2014.09.009

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  78 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.

Authors:  Tina R Hubler; Jonathan G Scammell
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

3.  Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.

Authors:  Andrew Skildum; Emily Faivre; Carol A Lange
Journal:  Mol Endocrinol       Date:  2004-10-14

4.  Human progesterone receptor displays cell cycle-dependent changes in transcriptional activity.

Authors:  Ramesh Narayanan; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Progesterone inhibits human breast cancer cell growth through transcriptional upregulation of the cyclin-dependent kinase inhibitor p27Kip1 gene.

Authors:  Florence Gizard; Romain Robillard; Philippe Gervois; Anne Faucompré; Françoise Révillion; Jean-Philippe Peyrat; W Dean Hum; Bart Staels
Journal:  FEBS Lett       Date:  2005-09-27       Impact factor: 4.124

6.  Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.

Authors:  Cecilia Proietti; Mariana Salatino; Cinthia Rosemblit; Romina Carnevale; Adalí Pecci; Alberto R Kornblihtt; Alfredo A Molinolo; Isabel Frahm; Eduardo H Charreau; Roxana Schillaci; Patricia V Elizalde
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

7.  Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.

Authors:  Emily Faivre; Andy Skildum; Lisa Pierson-Mullany; Carol A Lange
Journal:  Steroids       Date:  2005-03-23       Impact factor: 2.668

8.  Roscovitine targets, protein kinases and pyridoxal kinase.

Authors:  Stéphane Bach; Marie Knockaert; Jens Reinhardt; Olivier Lozach; Sophie Schmitt; Blandine Baratte; Marcel Koken; Stephen P Coburn; Lin Tang; Tao Jiang; Dong-Cai Liang; Hervé Galons; Jean-Francois Dierick; Lorenzo A Pinna; Flavio Meggio; Frank Totzke; Christoph Schächtele; Andrea S Lerman; Amancio Carnero; Yongqin Wan; Nathanael Gray; Laurent Meijer
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

9.  Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.

Authors:  Ramesh Narayanan; Abayomi A Adigun; Dean P Edwards; Nancy L Weigel
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

10.  Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides.

Authors:  K Aaltonen; C Ahlin; R-M Amini; L Salonen; M-L Fjällskog; P Heikkilä; H Nevanlinna; C Blomqvist
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

View more
  5 in total

1.  Inhibiting Nuclear Phospho-Progesterone Receptor Enhances Antitumor Activity of Onapristone in Uterine Cancer.

Authors:  Yan Huang; Wei Hu; Jie Huang; Fangrong Shen; Yunjie Sun; Cristina Ivan; Sunila Pradeep; Robert Dood; Monika Haemmerle; Dahai Jiang; Lingegowda S Mangala; Kyunghee Noh; Jean M Hansen; Heather J Dalton; Rebecca A Previs; Archana S Nagaraja; Michael McGuire; Nicholas B Jennings; Russell Broaddus; Robert L Coleman; Anil K Sood
Journal:  Mol Cancer Ther       Date:  2017-12-13       Impact factor: 6.261

2.  Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK.

Authors:  Lindsey S Treviño; Michael J Bolt; Sandra L Grimm; Dean P Edwards; Michael A Mancini; Nancy L Weigel
Journal:  Mol Endocrinol       Date:  2015-12-11

Review 3.  Targeting cell-cycle machinery in cancer.

Authors:  Jan M Suski; Marcin Braun; Vladislav Strmiska; Piotr Sicinski
Journal:  Cancer Cell       Date:  2021-04-22       Impact factor: 38.585

4.  Ten hub genes associated with progression and prognosis of pancreatic carcinoma identified by co-expression analysis.

Authors:  Zhou Zhou; Yian Cheng; Yinan Jiang; Shi Liu; Meng Zhang; Jing Liu; Qiu Zhao
Journal:  Int J Biol Sci       Date:  2018-01-12       Impact factor: 6.580

5.  Screening and verifying key genes with poor prognosis in colon cancer through bioinformatics analysis.

Authors:  Buyuan Dong; Mengyu Chai; Hao Chen; Qian Feng; Rong Jin; Sunkuan Hu
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.